Medical Student Research Forum Posters

Cutaneous T-Cell Lymphomas (CTCL) are rarely seen clinically, with a global annual incidence of ​<10 per 100,000, and only 11% are CD30+ Lymphoproliferative disorders (LPD). Their heterogenous clinical and pathologic presentation result in significant diagnostic challenges. Diagnosis of potentially aggressive CTCL warrants prompt clinical, histopathological, and immunohistochemical evaluation. Management of the patient with suspected CTCL, as with other life-limiting disease, should include quality of life and goals of care assessment, as well as early inclusion of palliative care in medical management.​